Colombia's Ministry of Health confirmed a second mpox clade Ib case in Bogotá on May 1, identified through strengthened epidemiological surveillance. The patient is under home isolation with contact tracing initiated; authorities report no community transmission detected and that the general population risk level remains unchanged. With 4,830 cumulative cases registered between 2022-2026, health authorities maintain vigilance while emphasizing the situation remains under epidemiological control.